Tamil Nadu’s first Economic Survey 2024-25 has indicated that the State is expected to maintain a growth rate of above 8% in ...
Recent FDA feedback received on SER-155 allogeneic hematopoietic stem cell transplant (allo-HSCT) next study provides support for the proposed primary efficacy endpoint of reduction in bloodstream inf ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results